Filing Details

Accession Number:
0001209191-10-057582
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-01 16:35:28
Reporting Period:
2010-11-30
Filing Date:
2010-12-01
Accepted Time:
2010-12-01 16:35:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1108109 Community Health Systems Inc CYH Services-General Medical & Surgical Hospitals, Nec (8062) 133893191
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1451345 Dewayne Martin Smith 4000 Meridian Blvd
Franklin TN 37067
Division President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-30 10,000 $20.30 73,773 No 4 M Direct
Common Stock Disposition 2010-11-30 10,000 $0.00 63,773 No 4 S Direct
Common Stock Acquisiton 2010-11-30 3,333 $15.11 67,106 No 4 M Direct
Common Stock Disposition 2010-11-30 3,333 $0.00 63,773 No 4 S Direct
Common Stock Acquisiton 2010-11-30 3,333 $18.18 67,106 No 4 M Direct
Common Stock Disposition 2010-11-30 3,333 $0.00 63,773 No 4 S Direct
Common Stock Acquisiton 2010-11-30 2,000 $20.30 65,773 No 4 M Direct
Common Stock Disposition 2010-11-30 2,000 $0.00 63,773 No 4 S Direct
Common Stock Disposition 2010-11-30 21,272 $0.00 42,501 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2010-11-30 10,000 $20.30 10,000 $20.30
Common Stock Stock Options (Right to Buy) Disposition 2010-11-30 3,333 $15.11 3,333 $15.11
Common Stock Stock Options (Right to Buy) Disposition 2010-11-30 3,333 $18.18 3,333 $18.18
Common Stock Stock Options (Right to Buy) Disposition 2010-11-30 2,000 $20.30 2,000 $20.30
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-05-22 2013-05-22 No 4 M Direct
6,667 2009-12-10 2019-12-10 No 4 M Direct
6,667 2010-02-25 2019-02-25 No 4 M Direct
0 2004-05-22 2013-05-22 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Performance Based Restricted $0.00 40,000 40,000 Direct
Common Stock Stock Options (Right to Buy) $33.90 2011-02-24 2020-02-24 10,000 10,000 Direct
Common Stock Stock Options (Right to Buy) $27.70 2003-05-21 2012-05-21 2,000 2,000 Direct
Common Stock Stock Options (Right to Buy) $25.70 2004-12-09 2013-12-09 5,000 5,000 Direct
Common Stock Stock Options (Right to Buy) $25.13 2005-05-25 2014-05-25 2,000 2,000 Direct
Common Stock Stock Options (Right to Buy) $32.37 2006-02-28 2013-02-28 5,000 5,000 Direct
Common Stock Stock Options (Right to Buy) $38.30 2007-03-01 2014-03-01 3,000 3,000 Direct
Common Stock Stock Options (Right to Buy) $37.21 2008-02-28 2015-02-28 1,500 1,500 Direct
Common Stock Stock Options (Right to Buy) $32.28 2009-02-27 2018-02-27 1,500 1,500 Direct
Common Stock Stock Options (Right to Buy) $40.41 2008-07-25 2015-07-25 8,000 8,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
40,000 40,000 Direct
2020-02-24 10,000 10,000 Direct
2012-05-21 2,000 2,000 Direct
2013-12-09 5,000 5,000 Direct
2014-05-25 2,000 2,000 Direct
2013-02-28 5,000 5,000 Direct
2014-03-01 3,000 3,000 Direct
2015-02-28 1,500 1,500 Direct
2018-02-27 1,500 1,500 Direct
2015-07-25 8,000 8,000 Direct
Footnotes
  1. These shares were sold in a series of transactions at an average sales price of $31.9283 per share.
  2. These shares were sold in a series of transactions at an average sales price of $32.1016 per share.
  3. Each performance based restricted share represents a contingent right to receive one share of CYH common stock. There are two elements to the lapsing of the restriction; first, the Company must achieve specified targeted amount of earnings per share from continuing operations, or net revenue from continuing operations, and if the performance objective is met, the vesting restrictions will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. If the objectives are not met, the shares will be forfeited.